Recent News

559 News Items found
Ankita Dhar and Jason De La Cruz at work in MSK's cryo-EM facility
How cryo-electron microscopy is providing scientists at MSK with an unprecedented view of the wild and wiggly microcosm inside our cells.
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024
New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
A researcher working in an MSK lab
New MSK research uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.
MSK PhD graduate Renhe Luo
Profile
Read about the research of Renhe Luo, winner of the 2024 GSK Chairman’s Prize, who studies gene enhancers.
An MSK scientists works in the lab
MSK Research Highlights, August 13, 2024
New MSK research found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.
MSK lab coat
A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.
MSK Awards & Appointments January 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Andrea Schietinger
In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
Ellen Horste
Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.
Pancreatic cancer cells
MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.